{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:43:27Z","timestamp":1788615807884,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nasopharyngeal carcinoma (NPC) is one of the most malignant tumors in southern China and Asia, and lymph node metastasis is an important cause for treatment failure. Lymphangiogenesis is a crucial step in lymphatic metastasis of NPC, while little is known about lymphangiogenesis in NPC. Similar to angiogenesis, lymphangitic neovascularization is a process of balance between pro-lymphangiogenesis and anti-lymphangiogenesis factors, but there are few studies on endogenous lymphangiogenesis inhibitors. Pigment epithelium-derived factor (PEDF) is a well-known effective endogenous angiogenesis inhibitor. However, the relationship between PEDF and lymphangiogenesis remains unknown. Our present study reveals that PEDF is lowly expressed in human NPC tissues with poor prognosis and is negatively correlated with lymphatic vessel density (LVD). Consistently, PEDF inhibits lymphangiogenesis and lymphatic metastasis of NPC in vivo experiments. Mechanistically, PEDF inhibits the proliferation, migration, and tube formation of lymphatic endothelial cells and promotes cell apoptosis. On the other hand, PEDF reduces the expression and secretion of vascular endothelial growth factor C (VEGF-C) of NPC cells through the nuclear factor-\u03baB (NF-\u03baB) signaling pathway. Our findings indicate that PEDF plays a vital role in lymphatic metastasis by targeting both lymphatic endothelial cells and NPC cells, and PEDF may represent a novel therapeutic target for NPC.<\/jats:p>","DOI":"10.1038\/s41419-021-03583-1","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T15:02:51Z","timestamp":1615993371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8188-6581","authenticated-orcid":false,"given":"Chuanghua","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zumin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-9689","authenticated-orcid":false,"given":"Guoquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-5405","authenticated-orcid":false,"given":"Ti","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"3583_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"3583_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394, 64\u201380 (2019).","journal-title":"Lancet"},{"key":"3583_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/0360-3016(90)90014-B","volume":"19","author":"JS Sham","year":"1990","unstructured":"Sham, J. S., Choy, D. & Wei, W. I. Nasopharyngeal carcinoma: orderly neck node spread. Int. J. Radiat. Oncol. Biol. Phys. 19, 929\u2013933 (1990).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3583_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","volume":"61","author":"AW Lee","year":"2005","unstructured":"Lee, A. W. et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int. J. Radiat. Oncol. Biol. Phys. 61, 1107\u20131116 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3583_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0030-4220(93)90402-P","volume":"75","author":"JB Epstein","year":"1993","unstructured":"Epstein, J. B. & Jones, C. K. Presenting signs and symptoms of nasopharyngeal carcinoma. Oral. Surg. Oral. Med. Oral. Pathol. 75, 32\u201336 (1993).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol."},{"key":"3583_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-98","volume":"12","author":"FC Ho","year":"2012","unstructured":"Ho, F. C., Tham, I. W., Earnest, A., Lee, K. M. & Lu, J. J. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer 12, 98 (2012).","journal-title":"BMC Cancer"},{"key":"3583_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N","volume":"22","author":"AD King","year":"2000","unstructured":"King, A. D. et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head. Neck 22, 275\u2013281 (2000).","journal-title":"Head. Neck"},{"key":"3583_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coi.2018.05.002","volume":"53","author":"G Varricchi","year":"2018","unstructured":"Varricchi, G. et al. Innate effector cells in angiogenesis and lymphangiogenesis. Curr. Opin. Immunol. 53, 152\u2013160 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"3583_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker, S. A. et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 14, 159\u2013172 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"3583_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela, T. & Alitalo, K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140, 460\u2013476 (2010).","journal-title":"Cell"},{"key":"3583_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/cr.2010.116","volume":"20","author":"L Zhang","year":"2010","unstructured":"Zhang, L. et al. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 20, 1319\u20131331 (2010).","journal-title":"Cell Res."},{"key":"3583_CR12","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1038\/onc.2011.602","volume":"31","author":"A Alitalo","year":"2012","unstructured":"Alitalo, A. & Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31, 4499\u20134508 (2012).","journal-title":"Oncogene"},{"key":"3583_CR13","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1182\/blood-2013-12-297317","volume":"123","author":"S Coso","year":"2014","unstructured":"Coso, S., Bovay, E. & Petrova, T. V. Pressing the right buttons: signaling in lymphangiogenesis. Blood 123, 2614\u20132624 (2014).","journal-title":"Blood"},{"key":"3583_CR14","doi-asserted-by":"publisher","first-page":"9261","DOI":"10.1158\/0008-5472.CAN-04-2345","volume":"65","author":"MA Bjorndahl","year":"2005","unstructured":"Bjorndahl, M. A. et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65, 9261\u20139268 (2005).","journal-title":"Cancer Res."},{"key":"3583_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1084\/jem.20041896","volume":"201","author":"S Hirakawa","year":"2005","unstructured":"Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089\u20131099 (2005).","journal-title":"J. Exp. Med."},{"key":"3583_CR16","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/sj.emboj.7600763","volume":"24","author":"K Kajiya","year":"2005","unstructured":"Kajiya, K., Hirakawa, S., Ma, B., Drinnenberg, I. & Detmar, M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 24, 2885\u20132895 (2005).","journal-title":"EMBO J."},{"key":"3583_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood-2012-08-450502","volume":"121","author":"N Platonova","year":"2013","unstructured":"Platonova, N. et al. Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1. Blood 121, 1229\u20131237 (2013).","journal-title":"Blood"},{"key":"3583_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/jid.2012.272","volume":"133","author":"A Bracher","year":"2013","unstructured":"Bracher, A. et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J. Invest. Dermatol. 133, 230\u2013238 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"3583_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","volume":"6","author":"R Cao","year":"2004","unstructured":"Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333\u2013345 (2004).","journal-title":"Cancer Cell"},{"key":"3583_CR20","doi-asserted-by":"publisher","first-page":"15593","DOI":"10.1073\/pnas.0507865102","volume":"102","author":"M Bjorndahl","year":"2005","unstructured":"Bjorndahl, M. et al. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc. Natl Acad. Sci. USA 102, 15593\u201315598 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3583_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13402-016-0281-9","volume":"39","author":"R Paduch","year":"2016","unstructured":"Paduch, R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. 39, 397\u2013410 (2016).","journal-title":"Cell Oncol."},{"key":"3583_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10585-005-3973-5","volume":"22","author":"S Fukumoto","year":"2005","unstructured":"Fukumoto, S., Morifuji, M., Katakura, Y., Ohishi, M. & Nakamura, S. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells. Clin. Exp. Metastasis 22, 31\u201338 (2005).","journal-title":"Clin. Exp. Metastasis"},{"key":"3583_CR23","doi-asserted-by":"publisher","first-page":"11528","DOI":"10.1158\/0008-5472.CAN-07-1458","volume":"67","author":"G Brideau","year":"2007","unstructured":"Brideau, G. et al. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 67, 11528\u201311535 (2007).","journal-title":"Cancer Res."},{"key":"3583_CR24","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1038\/sj.onc.1205956","volume":"21","author":"T Hawighorst","year":"2002","unstructured":"Hawighorst, T. et al. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 21, 7945\u20137956 (2002).","journal-title":"Oncogene"},{"key":"3583_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1084\/jem.20092277","volume":"208","author":"C Cursiefen","year":"2011","unstructured":"Cursiefen, C. et al. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J. Exp. Med. 208, 1083\u20131092 (2011).","journal-title":"J. Exp. Med."},{"key":"3583_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm.2018","volume":"15","author":"RJ Albuquerque","year":"2009","unstructured":"Albuquerque, R. J. et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 15, 1023\u20131030 (2009).","journal-title":"Nat. Med."},{"key":"3583_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10120-017-0787-5","volume":"21","author":"C Ma","year":"2018","unstructured":"Ma, C. et al. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion. Gastric Cancer 21, 617\u2013631 (2018).","journal-title":"Gastric Cancer"},{"key":"3583_CR28","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3892\/ijo.2017.3972","volume":"50","author":"C Ma","year":"2017","unstructured":"Ma, C. et al. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation. Int. J. Oncol. 50, 2000\u20132010 (2017).","journal-title":"Int. J. Oncol."},{"key":"3583_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10824","volume":"7","author":"HL Wong","year":"2016","unstructured":"Wong, H. L. et al. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis. Nat. Commun. 7, 10824 (2016).","journal-title":"Nat. Commun."},{"key":"3583_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.exer.2005.10.016","volume":"82","author":"SP Becerra","year":"2006","unstructured":"Becerra, S. P. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp. Eye Res. 82, 739\u2013740 (2006).","journal-title":"Exp. Eye Res."},{"key":"3583_CR31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1073\/pnas.90.4.1526","volume":"90","author":"FR Steele","year":"1993","unstructured":"Steele, F. R., Chader, G. J., Johnson, L. V. & Tombran-Tink, J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl Acad. Sci. USA 90, 1526\u20131530 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3583_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrc3484","volume":"13","author":"SP Becerra","year":"2013","unstructured":"Becerra, S. P. & Notario, V. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat. Rev. Cancer 13, 258\u2013271 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"3583_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mce.2014.11.006","volume":"401","author":"R Carnagarin","year":"2015","unstructured":"Carnagarin, R., Dharmarajan, A. M. & Dass, C. R. PEDF-induced alteration of metabolism leading to insulin resistance. Mol. Cell Endocrinol. 401, 98\u2013104 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"3583_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink, J. & Barnstable, C. J. PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 4, 628\u2013636 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"3583_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov, V. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 1751 (1996).","journal-title":"EMBO J."},{"key":"3583_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc863","volume":"2","author":"SA Stacker","year":"2002","unstructured":"Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E. & Alitalo, K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2, 573\u2013583 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"3583_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10456-013-9386-1","volume":"17","author":"YH Huang","year":"2014","unstructured":"Huang, Y. H. et al. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells. Angiogenesis 17, 407\u2013418 (2014).","journal-title":"Angiogenesis"},{"key":"3583_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0930-x","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCepsilon-NF-kappaB signaling pathway and VEGF-C\/ Bcl-2 expression. Mol. Cancer 18, 1 (2019).","journal-title":"Mol. Cancer"},{"key":"3583_CR39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1053\/j.gastro.2017.07.042","volume":"153","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y. et al. BRCA1-associated protein increases invasiveness of esophageal squamous cell carcinoma. Gastroenterology 153, 1304\u20131319 (2017).","journal-title":"Gastroenterology"},{"key":"3583_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/bjd.12688","volume":"170","author":"I Pastushenko","year":"2014","unstructured":"Pastushenko, I. et al. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. Br. J. Dermatol. 170, 66\u201377 (2014).","journal-title":"Br. J. Dermatol."},{"key":"3583_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addr.2015.12.011","volume":"99","author":"LC Dieterich","year":"2016","unstructured":"Dieterich, L. C. & Detmar, M. Tumor lymphangiogenesis and new drug development. Adv. Drug Deliv. Rev. 99, 148\u2013160 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3583_CR42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ejca.2010.10.009","volume":"47","author":"S Luangdilok","year":"2011","unstructured":"Luangdilok, S., Box, C., Harrington, K., Rhys-Evans, P. & Eccles, S. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur. J. Cancer 47, 520\u2013529 (2011).","journal-title":"Eur. J. Cancer"},{"key":"3583_CR43","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.oraloncology.2012.02.003","volume":"48","author":"N Wakisaka","year":"2012","unstructured":"Wakisaka, N. et al. Induction of lymphangiogenesis through vascular endothelial growth factor-C\/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma. Oral. Oncol. 48, 703\u2013708 (2012).","journal-title":"Oral. Oncol."},{"key":"3583_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden, M. S. & Ghosh, S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203\u2013234 (2012).","journal-title":"Genes Dev."},{"key":"3583_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12, 695\u2013708 (2011).","journal-title":"Nat. Immunol."},{"key":"3583_CR46","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1111\/j.1349-7006.2009.01332.x","volume":"100","author":"H Yang","year":"2009","unstructured":"Yang, H. et al. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity. Cancer Sci. 100, 2419\u20132425 (2009).","journal-title":"Cancer Sci."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03583-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:38:32Z","timestamp":1669919912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["3583"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03583-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that the manuscript was given by the Medical Ethics Committee of Zhong Shan medical school.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"295"}}